Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VARENICLINE 1MG TABLET Resolved 2024-08-09 2024-08-23 234996
APO-VARENICLINE 1MG TABLET Resolved 2024-09-12 2024-11-15 237348
APO-VARENICLINE 0.5MG TABLET Resolved 2020-02-05 2020-03-27 105367
APO-VARENICLINE 1MG TABLET Resolved 2020-07-23 2020-08-10 120988
APO-VARENICLINE 1MG TABLET Resolved 2021-05-07 2025-01-31 138992
APO-VARENICLINE 1MG TABLET Resolved 2020-09-02 2020-09-14 123586
APO-VARENICLINE 0.5MG 1MG KIT TABLET Resolved 2020-09-02 2020-09-14 123589
APO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-04-21 2023-09-01 189999
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-16 2018-03-08 10442
APO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Resolved 2022-09-01 2022-09-16 168356
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-09-01 2022-11-20 168353
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-05-12 2023-09-01 192361
APO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-06-09 2023-08-18 194581
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-06-23 2023-09-01 196306
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-04-10 2018-11-03 45353
APO-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Actual shortage 2022-12-16 2023-08-18 178766
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-09 2023-01-13 177618
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2020-01-29 2020-09-14 104700
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-07-02 86347
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-06-24 86364
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2018-09-08 2018-09-08 60753
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-02-13 60763
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-07-13 60758
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2019-02-05 60778
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-12-28 60766
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-08-08 60772
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-02-13 60769
APO-SALVENT TABLETS - 2MG 2MG TABLET Discontinued 2018-02-23 2018-12-28 40854
APO-SALVENT TABLETS - 4MG 4MG TABLET Discontinued 2018-02-23 2018-07-17 40847
APO-SERTRALINE 100MG CAPSULE Discontinued 2018-09-08 2018-09-15 60781
APO-SILDENAFIL 100MG TABLET Discontinued 2018-09-08 2018-09-15 60784
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-SIMVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-11-19 60793
APO-SIMVASTATIN 10MG TABLET Discontinued 2018-09-08 2018-12-28 60790
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272